BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4913783)

  • 1. Autoimmunization with irradiated tumour cells in human malignant melanoma.
    Ikonopisov RL; Lewis MG; Hunter-Craig ID; Bodenham DC; Phillips TM; Cooling CI; Proctor J; Fairley GH; Alexander P
    Br Med J; 1970 Jun; 2(5712):752-4. PubMed ID: 4913783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma.
    Currie GA; Lejeune F; Fairley GH
    Br Med J; 1971 May; 2(5757):305-10. PubMed ID: 4930209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease.
    Lewis MG; Ikonopisov RL; Nairn RC; Phillips TM; Fairley GH; Bodenham DC; Alexander P
    Br Med J; 1969 Sep; 3(5670):547-52. PubMed ID: 4896110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of autoimmunization with irradiated tumour cells on specific cell-mediated immunity in patients with malignant melanoma.
    Currie GA
    Proc R Soc Med; 1972 Feb; 65(2):144-7. PubMed ID: 4563684
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoimmune reactions in uveal melanoma.
    Rahi AH
    Br J Ophthalmol; 1971 Dec; 55(12):793-807. PubMed ID: 4946074
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating antibodies in malignant melanoma patients.
    Betterle C; Peserico A; Bersani G; Ninfo V; Del Prete GF; Stefani R; Nitti D
    Dermatologica; 1979; 159(1):24-9. PubMed ID: 383530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in distribution of human malignant melanoma membrane antigens in the presence of human antibody by immunofluorescence.
    Leong SP; Sutherland CM; Krementz ET
    Cancer Res; 1977 Jan; 37(1):293-8. PubMed ID: 318607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of tumor specific immune reactions in human melanoma.
    Fairley GH; Lewis MG; Ikonopisov RL; Nairn RC; Alexander P
    Ann N Y Acad Sci; 1971 Jun; 177():286-9. PubMed ID: 4945666
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoimmunization in human malignant melanoma.
    van den Brenk HA
    Br Med J; 1969 Oct; 4(5676):171-2. PubMed ID: 5823074
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-tumour auto-antibody in human malignant melanoma.
    Mansell PW; Verrier-Jones J
    J Pathol; 1971 Feb; 103(2):Pxv. PubMed ID: 4936065
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.
    Soiffer R; Hodi FS; Haluska F; Jung K; Gillessen S; Singer S; Tanabe K; Duda R; Mentzer S; Jaklitsch M; Bueno R; Clift S; Hardy S; Neuberg D; Mulligan R; Webb I; Mihm M; Dranoff G
    J Clin Oncol; 2003 Sep; 21(17):3343-50. PubMed ID: 12947071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host factors in human malignant melanoma.
    Lewis MG
    Pathol Annu; 1971; 6():171-95. PubMed ID: 4949366
    [No Abstract]   [Full Text] [Related]  

  • 13. Serological detection of common human melanoma membrane antigens by microcomplement fixation and immunofluorescence.
    Leong SP; Cooperband SR; Deckers PJ; Sutherland CM; Fried RM; Krementz ET
    Oncology; 1983; 40(2):95-101. PubMed ID: 6338430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future.
    Gutterman JU; Mavligit G; Reed R; Richman S; McBride CE; Hersh EM
    Semin Oncol; 1975 Jun; 2(2):155-74. PubMed ID: 790574
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumour-associated antigens and tumour-host interactions.
    Baldwin RW
    Proc R Soc Med; 1971 Oct; 64(10):1039-42. PubMed ID: 4335921
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunity and human malignant melanoma.
    Br Med J; 1970 Jun; 2(5712):743-4. PubMed ID: 5428732
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased immunogenicity of B16 melanoma clones selected for their ability to metastasize from a heterogeneous primary tumor.
    Steele GD; Richie JP; Wang BS; Mannick JA; Wilson RE
    Surg Forum; 1979; 30():132-3. PubMed ID: 538574
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transplantation and tumour immunology].
    Schneeweiss U
    Dtsch Gesundheitsw; 1969 Oct; 24(43):2017-23 concl. PubMed ID: 4903978
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoimmune vitiligo: detection of antibodies to melanin-producing cells.
    Hertz KC; Gazze LA; Kirkpatrick CH; Katz SI
    N Engl J Med; 1977 Sep; 297(12):634-7. PubMed ID: 331108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
    Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
    Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.